Healthcare provider profile · identity verified

Maura E. Munoz, M.D.

Family Practice · SPRINGFIELD, MA · NPI 1871736728

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	309	69
Gabapentin	Gabapentin	234	41
Amlodipine Besylate	Amlodipine Besylate	199	40
Omeprazole	Omeprazole	172	37
Lisinopril	Lisinopril	163	32
Oxycodone Hcl	Oxycodone Hcl	145	28
Albuterol Sulfate Hfa	Albuterol Sulfate	136	31
Metformin Hcl	Metformin Hcl	135	27
Trulicity	Dulaglutide	127	18
Levothyroxine Sodium	Levothyroxine Sodium	123	24
Pantoprazole Sodium	Pantoprazole Sodium	112	21
Eliquis	Apixaban	109	18
Diclofenac Sodium	Diclofenac Sodium	100	31
Metoprolol Succinate	Metoprolol Succinate	98	18
Ventolin Hfa	Albuterol Sulfate	92	24
Famotidine	Famotidine	90	20
Tramadol Hcl	Tramadol Hcl	84	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	16
Fluticasone Propionate	Fluticasone Propionate	81	23
Hydrochlorothiazide	Hydrochlorothiazide	79	18
Pregabalin	Pregabalin	71	11
Simvastatin	Simvastatin	71	12
Jardiance	Empagliflozin	69	14
Losartan Potassium	Losartan Potassium	68	21
Furosemide	Furosemide	64	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	62	17
Pravastatin Sodium	Pravastatin Sodium	58	12
Carvedilol	Carvedilol	53	13
Metformin Hcl Er	Metformin Hcl	52	13
Sertraline Hcl	Sertraline Hcl	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	48	suppressed
Trazodone Hcl	Trazodone Hcl	48	suppressed
Ozempic	Semaglutide	47	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Montelukast Sodium	Montelukast Sodium	42	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	39	12
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Meloxicam	Meloxicam	32	12
Chlorthalidone	Chlorthalidone	31	suppressed
Naproxen	Naproxen	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Levemir Flexpen	Insulin Detemir	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Baclofen	Baclofen	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Finasteride	Finasteride	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	24	suppressed
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Novolog	Insulin Aspart	17	suppressed
Trulance	Plecanatide	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Topiramate	Topiramate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Torsemide	Torsemide	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Diclofenac Potassium	Diclofenac Potassium	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Prednisone	Prednisone	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error